Keith Krehbiel, who lived with Parkinson's disease for nearly 25 years, opted for deep-brain stimulation after his symptoms worsened. The process involves inserting wires into the brain to regulate movement by delivering electrical pulses. Approximately 200,000 people have had the procedure since it was approved, with 40,000 receiving advanced devices capable of monitoring and adapting to brain activity. The first clinical trial of adaptive deep-brain stimulation, with Krehbiel as a participant, is under review for results that could benefit millions currently affected by Parkinson's disease.
Krehbiel's experience with Parkinson's disease led him to undergo deep-brain stimulation, which involves wires inserted into the brain to deliver electrical pulses.
The technology aims to normalize aberrant brain activity, potentially reducing tremors and rigidity associated with Parkinson's disease.
Approximately 40,000 patients with newer devices received a feature that can read brain waves and adapt stimulation, akin to a cardiac pacemaker.
The ADAPT-PD trial results are under review, but initial findings suggested enough promise for regulatory approval in both the US and Europe.
Collection
[
|
...
]